Biblio

Author Title Type [ Year

]

Filters: First Letter Of Title is P [Clear All Filters]

2020

Michels BE, Mosa MH, Streibl BI, Zhan T, Menche C, Abou-El-Ardat K, Darvishi T, Członka E, Wagner S, Winter J, et al. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. Cell Stem Cell. 2020.

Adati EMonteiro, da Silva PMoreira, Sumita LMassami, Souza Mde Oliveir, Zanetti LP, Santos ACláudia F, de Souza MP, Colturato VR, Machado CM. Poor response to Hepatitis A Vaccination in Hematopoietic Stem Cell Transplant Recipients. Transpl Infect Dis. 2020:e13258.

Labriffe M, Vaidie J, Monchaud C, Debord J, Turlure P, Girault S, Marquet P, Woillard J-B. Population Pharmacokinetics and Bayesian Estimators for Intravenous Mycophenolate Mofetil in Haematopoietic Stem Cell Transplant Patients. Br J Clin Pharmacol. 2020.

Franck B, Woillard J-B, Théorêt Y, Bittencourt H, Demers E, Briand A, Marquet P, Lapeyraque A-L, Ovetchkine P, Autmizguine J. Population pharmacokinetics of ganciclovir and valganciclovir in pediatric solid organ and stem cell transplant recipients. Br J Clin Pharmacol. 2020.

Ning P, Huang L, Bao Y, Fu Y, Xu C, Shen Y, Zhou X, Wen X, Cheng Y, Qin Y. Portfolio Targeting Strategy To Realize the Assembly and Membrane Fusion-Mediated Delivery of Gold Nanoparticles to Mitochondria for Enhanced NIR Photothermal Therapies. Bioconjug Chem. 2020.

Marcon AR, Allan D, Barber M, Murdoch B, Caulfield T. Portrayal of umbilical cord blood research in the North American popular press: promise or hype?. Regen Med. 2020.

Yan T, Naren D, Gong Y. Positive expression of indicates poor prognosis of pediatric and adolescent AML patients. Expert Rev Hematol. 2020:1-9.

Chen K, Chen L, Li L, Qu S, Yu B, Sun Y, Wan F, Chen X, Liang R, Zhu X. A positive feedback loop between Wnt/β-catenin signaling and hTERT regulates the cancer stem cell-like traits in radioresistant nasopharyngeal carcinoma cells. J Cell Biochem. 2020.

Bar Droma E, Beck G, Ilgiyaev A, Fruchtman Y, Abramovitch-Dahan C, Levaot N, Givol N. Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism. J Oral Maxillofac Surg. 2020.

Iyama S, Tatsumi H, Shiraishi T, Yoshida M, Tatekoshi A, Endo A, Ishige T, Shiwa Y, Ibata S, Goto A, et al. Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective study. Nutrition. 2020;83:111093.

De Maria S, Fuggetta MPia, Rocchetti R, Cottarelli A, Lanzilli G, Stiuso P, Santoro A, Angelico G, Spadola S, Zannoni GFranco, et al. A possible interplay between HR-HPV and stemness in tumor development: An in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18 infected kb cell-line. APMIS. 2020.

Wormstone IM, Wormstone YM, Smith AJO, Eldred JA. Posterior capsule opacification: What's in the bag?. Prog Retin Eye Res. 2020:100905.

Behfar M, Babaei M, Radmard AReza, Kooraki S, Farajifard H, Naji P, Taebi S, Hamidieh AAli. Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study. Biol Blood Marrow Transplant. 2020.

Chen Q, Zhao X, Fu H-X, Chen Y-H, Zhang Y-Y, Wang J-Z, Wang Y, Wang F-R, Mo X-D, Han W, et al. Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant. 2020.

Komada M, Nagao T, Kagawa N. Postnatal di-2-ethylhexyl phthalate exposure affects hippocampal dentate gyrus morphogenesis. J Appl Toxicol. 2020.

West HL, Corbin KL, D'Angelo CV, Donovan LM, Jahan I, Gu G, Nunemaker CS. Postnatal maturation of calcium signaling in islets of Langerhans from neonatal mice. Cell Calcium. 2020;94:102339.

Szücs A, Paku S, Sebestyén E, Nagy P, Dezső K. Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation. PLoS One. 2020;15(5):e0233736.

Xiang Q-Y, Tian F, Du X, Xu J, Zhu L-Y, Guo L-L, Wen T, Liu Y-S, Liu L. Postprandial triglyceride-rich lipoproteins-induced premature senescence of adipose-derived mesenchymal stem cells via the SIRT1/p53/Ac-p53/p21 axis through oxidative mechanism. Aging (Albany NY). 2020;12.

Bouchacourt B, Hospital MA, Zemmour C, Rey J, d'Incan E, Charbonnier A, Mohty B, Saillard C, Bonnet S, Collignon A, et al. Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome. Ann Hematol. 2020.

Borlenghi E, Cattaneo C, Cerqui E, Archetti S, Bertoli D, Bellotti D, Gramegna D, Soverini G, Oberti M, Schieppati F, et al. Post-remission Therapy with Repeated Courses of High Dose Cytarabine, Idarubicin and Limited Autologous Stem Cell Support Achieves a Very Good Long-Term Outcome in ELN Favorable and Intermediate-Risk AML. Hematol Oncol. 2020.

Esrick EB, Lehmann LE, Biffi A, Achebe M, Brendel C, Ciuculescu MF, Daley H, MacKinnon B, Morris E, Federico A, et al. Post-Transcriptional Genetic Silencing of to Treat Sickle Cell Disease. N Engl J Med. 2020.

Chua BA, Van Der Werf I, Jamieson C, Signer RAJ. Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells. Cell Stem Cell. 2020;26(2):138-159.

Kunacheewa C, Owattanapanish W, Jirabanditsakul C, Issaragrisil S. Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations. Cell Transplant. 2020;29:963689720965900.

Alanazi W, Chen S, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Al-Shaibani Z, Mattsson J, et al. Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome. Acta Haematol. 2020:1-8.

Berro M, Rivas M, Trucco J, Paganini I, Ravchina I, Kusminsky G. Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center experienc. Bone Marrow Transplant. 2020.

Pages